Agoracom: Small Cap Investment - Mosaic ImmunoEngineering Inc. - Re: Do we have an offense? - IMO: No.

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

SGE1

Rank: President [?]

Points: 26670 [?]

Votes: 187 Score: 3.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Do we have an offense? - IMO: No. - gcduck

in response to

Re: Do we have an offense? - IMO: No. - gcduck

SGE1

posted on Jun 20, 2010 03:40PM

I intend to add the following to the end to exemplify the "financial destruction":

- Share price "high" before first Office Action on the original re-exam request: $2.25

- Share price high upon NIRC on prior re-exams: $0.36 (recognizing that it was known that a follow-on request for re-exam was in process - basis unknown)

- Share price today: $0.09 (while awaiting the USPTO to formally recognize the fact that, per statutory instruction and mere common sense, the current re-exam should never have been approved)